Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anthracyclines and proteasome inhibitors: effects on the ubiquitin cycle
NL-OMON31019Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxorubicin and bortezomib in hematopoietic malignancies and cancer, sponsored by Amsterdam University Medical Center. Planned start Sep 2007; status: not yet recruiting.
02
Drugs
doxorubicinbortezomib
03
Conditions
hematopoietic malignanciescancer
Beyond the preview
Go deeper on NL-OMON31019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31019.